Vinay Prasad has left his post at the US Food and Drug Administration (FDA) less than three months after joining the agency.

Japanese drugmaker Takeda has announced earnings results for the first quarter of Japan’s fiscal year 2025, ending June 30.

The UK’s National Institute for Health and Care Excellence (NICE) has issued a positive recommendation for the use of ...

USA-based Madrigal Pharmaceuticals today announced that it has entered into an exclusive global license agreement with CSPC ...

US biopharma Viridian Therapeutics has entered into an exclusive collaboration and license agreement with Japanese firm Kissei Pharmaceutical (TYO: 4547) to develop and commercialize veligrotug and ...

US pharma giant Pfizer has criticized the recent inclusion of the company in the list of enterprises that should be denied ...

LTZ Therapeutics, a Sino-American biotech focused on immunotherapy, has announced a strategic research collaboration with US ...

Swiss pharma company Idorsia today released encouraging first half 2025 financial results, sending its shares up 8.5% to 2.94 ...

Germany’s Evotec today announced a non-binding agreement with Switzerland’s Sandoz regarding the potential sale of Just – ...

Shares of DURECT Corporation shot up 240% to $1.88 by close of trading Tuesday, after Canada’s Bausch Health agreed to ...

Artbio, a US biotech specializing in radiopharmaceuticals, has raised $132 million in a series B financing to move its lead ...

A major US trial has found that structured healthy lifestyle programs can slow memory loss in older adults, regardless of ...